LPS uses a different framework of signaling molecules such as TLR4, MyD88, Mal, and IKK2 to activate NF-κB and induce NF-κB–dependent cytokine production in human nonmyeloid (SFs and HUVECs) and myeloid cells (macrophages and dendritic cells).